000 | 01969 a2200553 4500 | ||
---|---|---|---|
005 | 20250516100138.0 | ||
264 | 0 | _c20121023 | |
008 | 201210s 0 0 eng d | ||
022 | _a2219-2840 | ||
024 | 7 |
_a10.3748/wjg.v18.i22.2844 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Xiang-Yu | |
245 | 0 | 0 |
_aXAF1 is frequently methylated in human esophageal cancer. _h[electronic resource] |
260 |
_bWorld journal of gastroenterology _cJun 2012 |
||
300 |
_a2844-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aApoptosis Regulatory Proteins |
650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aChina |
650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
650 | 0 | 4 |
_aDNA Modification Methylases _xantagonists & inhibitors |
650 | 0 | 4 | _aDecitabine |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
650 | 0 | 4 |
_aEsophageal Neoplasms _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
700 | 1 | _aHe, Qiao-Yu | |
700 | 1 | _aGuo, Ming-Zhou | |
773 | 0 |
_tWorld journal of gastroenterology _gvol. 18 _gno. 22 _gp. 2844-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v18.i22.2844 _zAvailable from publisher's website |
999 |
_c21882904 _d21882904 |